Pomelo Care Named to the 2026 New York Digital Health 100

DH100 recognizes the companies shaping the future of healthcare innovation in NY

New York, NY, February 3, 2026 – Pomelo Care, the national leader in evidence-based healthcare for women and children, announced today that it has been named to the 2026 New York Digital Health 100 (DH100), an annual recognition honoring the most innovative and high-impact digital health startups in the New York region. Published by Digital Health New York (DHNY), the DH100 is released in conjunction with the 2026 New York Healthcare Innovation Report, which analyzes key investment trends, market dynamics, and opportunities shaping the digital health ecosystem.

Now in its seventh year, the DH100 spotlights the companies driving healthcare forward through bold ideas and scalable solutions. The 2026 list includes 48 new companies addressing some of healthcare’s most complex challenges, alongside members of the DHNY Hall of Fame, which recognizes organizations whose early and lasting contributions helped build New York’s digital health ecosystem.

“Being named to the 2026 DH100 is a meaningful milestone for our team and an exciting way to start 2026,” said Marta Bralic Kerns, founder and CEO of Pomelo Care. “This recognition reflects our amazing team who show up every day to deliver care that meaningfully improves outcomes for patients across the United States and creates real value for the health plans and employers we partner with. We’re proud to be setting the new national standard for women’s and children’s healthcare from New York City, and grateful to DHNY for recognizing our work.”

“The breadth and depth of companies named to this year’s DH100 reflect a clear market shift from experimentation to execution,” said Bunny Ellerin, co-founder and CEO of DHNY. “These companies are scaling solutions that improve outcomes while building enduring businesses, demonstrating how innovation at the intersection of care delivery, data, and trust is shaping the next generation of healthcare leaders.”

The recognition follows a period of significant growth for Pomelo Care. In January 2026, the company announced a $92 million Series C to expand its proven virtual maternity care model beyond pregnancy and deliver evidence-based care for women and children across every stage of life. Pomelo now supports nearly 7% of U.S. births and partners with leading health plans and employers nationwide to improve outcomes, reduce costs, and expand access to high-quality care at scale.

To download a copy of the 2026 New York Healthcare Innovation Report, please click here.

About Pomelo Care

Pomelo Care is the national leader in evidence-based healthcare for women and children. We deliver personalized, high-quality clinical interventions from reproductive care and pregnancy, infant care and pediatrics, to hormonal health through perimenopause and menopause, with long-term preventive care and condition management. Our model delivers 24/7 multispecialty care to address the medical, behavioral, and social factors that most significantly impact outcomes for women and children. We partner with payers, employers, and providers to expand access to quality healthcare across the system. Learn more at pomelocare.com. 

About Digital Health New York (DHNY) 

Digital Health New York (DHNY) is a connected community of digital health leaders who share ideas, spark new directions and create success across the entire ecosystem. As an organization, DHNY seeks to increase the visibility of New York City as a leader in healthcare innovation and showcase the companies and leaders creating the future of healthcare. Its flagship event, DHNY Summit, brings together an elite group of entrepreneurs, investors, payers, providers and executives to cultivate the New York digital health community and drive impactful conversations around the current and future state of digital health. DHNY was founded in 2022 in collaboration with AlleyCorp. For more information or to join DHNY’s mailing list, please visit www.dhny.co.

DH100 Methodology 

To compile the DH100, DHNY invited companies to complete an in-depth application with both quantitative and qualitative measures to get to know the company better. DHNY also used its dynamic database of digital health companies in the region to round out the consideration set. A company qualified for consideration if it maintained headquarters or employed at least 5 people in the New York region. Companies were excluded if: public or non-profit; founded before 2015; on the DH100 five or more years; had an exit. DHNY evaluated companies on a number of factors, including but not limited to: strength of application, leadership, # of employees, funding, revenue, market fit, differentiated  offerings, and community engagement.